Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Country's Decision or any other Communication
(DEC)
last updated: 20 Jul 2026
No
Commercial Release of the PROTEQFLU Vaccine - Technical Opinion No. 5486/2017.
EN
08 Jun 2017
No
- Decision on LMOs for intentional introduction into the environment (according to Article 10 or domestic regulatory framework)
- Decision on LMOs for direct use as food or feed, or for processing (Article 11, LMOs-FFP)
No
Yes
-
Organization:Merial Saúde Animal Ltda (Merial)Private sector (business and industry)Fazenda São Francisco s/nº - Caixa Postal: 242 - PAULINIA (SP)Paulínia, São Paulo
13140970, BrazilPhone: +55 19 3874-8601,Fax: +55 19 3874-8080,Email: luciana.soares@merial.com.br,Website: http://www.merial.com.br,
Yes
Yes
Yes
- LMOs for processing
No
Approval of the import and/or use of the LMO(s) without conditions
Yes
No
No
-
BCH-LMO-SCBD-101612-7 Living Modified Organism Proteqflu - equine influenza vaccineMerial | Production of medical or pharmaceutical compounds (human or animal) (Vaccines), Use as vaccine
-
BCH-RA-BR-299896-1 Risk Assessment generated by a regulatory process Risk assessment of the PROTEQFLU Vaccine - Technical Opinion No. 5486/2017.Proteqflu - equine influenza vaccine | CNPV, Production of medical or pharmaceutical compounds (human or animal)
- Commercial release 5486-2017.pdf [ Portuguese ]
